Psychopathic personality traits stress immunity and social potency moderate the relationship between emotional competence and cognitive functions in depression.
affective disorders
cognitive functions
depression
emotional competence
personality
psychopathic personality traits
social potency
stress immunity
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
10
2022
accepted:
03
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Psychopathic personality traits (PPT) and depression have both been shown to worsen emotional and cognitive functions. Moreover, PPT and depression share similar underlying neuronal circuits tapping into the emotional and cognitive domains. However, little is known about the influence of PPT on emotion and cognition in individuals with depression. This study aimed to examine the correlative relationships and moderating role of PPT in the association between emotional competence and cognitive functions in individuals with depression. Data from 373 individuals diagnosed with depression (158 males, 215 females) were examined within a cohort study. Subjects filled out validated questionnaires surveying PPT and emotional competences. Furthermore, a comprehensive neuropsychological test battery was administered. Correlation analyses revealed a significant positive association between emotional competence and cognitive functions. Further, negative associations between emotional competence and the PPT "Blame Externalisation" and "Careless Nonplanfulness," as well as positive associations with psychopathic "Social Potency" and "Stress Immunity" were found. Moderation analyses indicated a significant positive influence of psychopathic "Stress Immunity" and "Social Influence" on the relationship between emotional competence and cognitive functions. The findings highlight the importance of integrating PPT in depression research. Considering PPT in depression treatment could also facilitate the therapeutic process by identifying individual traits as resilience-strengthening or potentially harmful factors for depressive symptomatology. This study represents a stepping stone for further research regarding the role of personality traits in psychiatric disorders and their treatment.
Sections du résumé
Background
UNASSIGNED
Psychopathic personality traits (PPT) and depression have both been shown to worsen emotional and cognitive functions. Moreover, PPT and depression share similar underlying neuronal circuits tapping into the emotional and cognitive domains. However, little is known about the influence of PPT on emotion and cognition in individuals with depression.
Objectives
UNASSIGNED
This study aimed to examine the correlative relationships and moderating role of PPT in the association between emotional competence and cognitive functions in individuals with depression.
Methods
UNASSIGNED
Data from 373 individuals diagnosed with depression (158 males, 215 females) were examined within a cohort study. Subjects filled out validated questionnaires surveying PPT and emotional competences. Furthermore, a comprehensive neuropsychological test battery was administered.
Results
UNASSIGNED
Correlation analyses revealed a significant positive association between emotional competence and cognitive functions. Further, negative associations between emotional competence and the PPT "Blame Externalisation" and "Careless Nonplanfulness," as well as positive associations with psychopathic "Social Potency" and "Stress Immunity" were found. Moderation analyses indicated a significant positive influence of psychopathic "Stress Immunity" and "Social Influence" on the relationship between emotional competence and cognitive functions.
Conclusion
UNASSIGNED
The findings highlight the importance of integrating PPT in depression research. Considering PPT in depression treatment could also facilitate the therapeutic process by identifying individual traits as resilience-strengthening or potentially harmful factors for depressive symptomatology. This study represents a stepping stone for further research regarding the role of personality traits in psychiatric disorders and their treatment.
Identifiants
pubmed: 37051168
doi: 10.3389/fpsyt.2023.1061642
pmc: PMC10084668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1061642Informations de copyright
Copyright © 2023 Schönthaler, Dalkner, Schwalsberger, Reininghaus and Reininghaus.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Psychosom Med. 2016 Jun;78(5):562-72
pubmed: 26910796
Psychiatry Res. 2014 Dec 15;220(1-2):483-9
pubmed: 25110313
J Affect Disord. 2006 Aug;94(1-3):219-29
pubmed: 16740316
J Affect Disord. 2021 May 1;286:19-26
pubmed: 33662715
Front Psychol. 2014 Jul 22;5:740
pubmed: 25101019
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Depress Anxiety. 2015 Jul;32(7):461-70
pubmed: 26014798
Psychophysiology. 2009 Sep;46(5):913-21
pubmed: 19497014
Aust N Z J Psychiatry. 2010 Aug;44(8):681-96
pubmed: 20636189
Psychol Rep. 2013 Apr;112(2):445-57
pubmed: 23833874
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Psychol Med. 2014 Jul;44(10):2029-40
pubmed: 24168753
Mol Psychiatry. 2016 Apr;21(4):500-8
pubmed: 26122585
Biol Psychiatry. 2009 Nov 1;66(9):879-85
pubmed: 19709646
Neuropsychology. 2008 Sep;22(5):669-80
pubmed: 18763886
Cogn Neuropsychiatry. 2006 May;11(3):285-306
pubmed: 17354073
Front Psychiatry. 2019 Feb 21;10:74
pubmed: 30846946
Crim Behav Ment Health. 2011 Oct;21(4):279-94
pubmed: 21469239
J Neuropsychiatry Clin Neurosci. 2013 Summer;25(3):233-6
pubmed: 24026716
Front Psychiatry. 2020 Feb 06;10:1027
pubmed: 32116828
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
Braz J Psychiatry. 2020;42(3):241-242
pubmed: 32074231
Neuropsychopharmacology. 2022 Jan;47(1):225-246
pubmed: 34341498
Am J Psychiatry. 2003 Aug;160(8):1516-8
pubmed: 12900317
Personal Disord. 2014 Apr;5(2):186-94
pubmed: 24341861
J Affect Disord. 2021 Dec 1;295:1220-1228
pubmed: 34706436
Personal Ment Health. 2020 Feb;14(1):30-50
pubmed: 31397079
J Pers Disord. 2007 Apr;21(2):142-59
pubmed: 17492918
World Psychiatry. 2015 Jun;14(2):158-60
pubmed: 26043325
Biol Psychol. 2019 Feb;141:35-43
pubmed: 30597188
J Affect Disord. 2019 Oct 1;257:38-44
pubmed: 31299403
Front Psychol. 2018 May 18;9:756
pubmed: 29867700
J Affect Disord. 2016 Jan 15;190:744-753
pubmed: 26606718
Psychiatry Res. 2006 Jun 15;142(2-3):107-28
pubmed: 16712954
Psychol Med. 2004 Aug;34(6):1059-64
pubmed: 15554576
Front Behav Neurosci. 2022 Sep 30;16:998714
pubmed: 36248028
Front Behav Neurosci. 2022 Jul 22;16:946263
pubmed: 35941933
Personal Disord. 2012 Jul;3(3):283-93
pubmed: 22452754
Personal Neurosci. 2019 Oct 23;2:e8
pubmed: 32435743
CNS Spectr. 2019 Feb;24(1):102-113
pubmed: 30591083
Mol Psychiatry. 2022 Feb;27(2):784-786
pubmed: 34667263
BMC Psychol. 2021 Oct 18;9(1):160
pubmed: 34663456
Biol Psychol. 2014 Dec;103:107-16
pubmed: 25179538
Neurosci Biobehav Rev. 2008;32(3):454-65
pubmed: 17915324
Neurosci Biobehav Rev. 2012 Nov;36(10):2288-304
pubmed: 22944264
Actas Esp Psiquiatr. 2015 Sep;43(5):187-93
pubmed: 26320897
Behav Sci Law. 2008;26(1):7-28
pubmed: 18327824
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33846145
J Psychiatry Neurosci. 2006 Sep;31(5):316-23
pubmed: 16951734
Soc Cogn Affect Neurosci. 2022 Jul 2;17(7):662-672
pubmed: 34878140
Transl Psychiatry. 2021 Feb 1;11(1):81
pubmed: 33518708
Biol Psychiatry. 2019 Sep 15;86(6):464-473
pubmed: 31292066
Psychiatry Res. 2019 Aug;278:151-161
pubmed: 31200194
Cogn Affect Behav Neurosci. 2017 Jun;17(3):491-515
pubmed: 28092055
Psychiatry Res. 2018 Dec;270:68-77
pubmed: 30245379
Psychiatry Res. 2020 Aug;290:113160
pubmed: 32526515
Curr Psychiatry Rep. 2019 Apr 27;21(6):37
pubmed: 31030293
J Affect Disord. 2021 May 15;287:247-254
pubmed: 33799044
Lancet Psychiatry. 2019 Oct;6(10):851-861
pubmed: 31422920
Neuropsychopharmacology. 2008 Jan;33(1):88-109
pubmed: 17851537
Schizophr Bull. 2016 May;42(3):608-18
pubmed: 26433217
Neuropsychology. 2007 May;21(3):301-312
pubmed: 17484593
World J Biol Psychiatry. 2005;6 Suppl 2:5-22
pubmed: 16166019
Behav Res Ther. 2016 Nov;86:35-49
pubmed: 27492851
Biol Psychol. 2013 Mar;92(3):541-8
pubmed: 23079384
Prog Brain Res. 2006;156:457-66
pubmed: 17015096
J Abnorm Psychol. 2014 Feb;123(1):214-24
pubmed: 24661171
Clin Psychol Rev. 2018 Feb;59:126-136
pubmed: 29195773
PLoS One. 2018 Jan 11;13(1):e0190714
pubmed: 29324826
Psychiatr Clin North Am. 2008 Sep;31(3):463-75, vii
pubmed: 18638646
Cogn Emot. 2010 Feb 1;24(2):281-98
pubmed: 20300538
Arch Gen Psychiatry. 2010 Oct;67(10):1002-11
pubmed: 20921116
Annu Rev Neurosci. 2010;33:173-202
pubmed: 20331363
Psychoneuroendocrinology. 2022 Oct;144:105861
pubmed: 35853382